Post Surgical Pain Patch Product

Market Potential

  • There are more than 50 million in-patient operations performed annually in the U.S. requiring pain relief for up to 5 days; in 2010 outpatient operations surpassed this and continue to grow
  • Many of the pain relief products available are narcotics, which can have severe side effects. Recent guidelines from the CDC recommend reducing opiate prescriptions.
  • A transdermal formulation with a non-narcotic drug mitigates the potential for abuse of a potent drug and provides sustained pain relief for 24 hours and can be applied daily for up to 5 days

Competition

  • Surgical pain can be intense (joint replacement surgery, cancer surgery, etc.)
  • Drugs used to treat this pain include the opiates, Oxycontin®, and fentanyl. These drugs have recently been targeted for rampant abuse.
  • Elliptical Therapeutics’ product utilizes a potent non-narcotic drug ketorolac tromethamine that is often used via injection or iv drip during surgery, and a nasal formulation used post-surgery; the patch could seamlessly move the patient from the operating room to post operative pain relief.
  • Our transdermal formulation mitigates the potential for abuse of a potent drug and provides sustained relief for 24 hours; additional patches can be administered over several days.
hospital senior check